Taylor Bloom is the Senior Intellectual Property Counsel for Verve. Taylor is experienced in trademark, patent, copyright and trade secret counseling and litigation. Ms. Bloom is responsible for all legal and administrative matters related to Verve's IP portfolio.
At Verve, Taylor has helped secured new patents protecting core company inventions. Ms. Bloom assesses patentability and freedom to operate in a range of cross discipline technologies to grow and diversify Verve’s IP portfolio while simultaneously evaluating competitor presence and legal enforceability. Taylor is also the 2016-2017 Chair of the Intellectual Property Section of the San Diego County Bar Association. In addition, Taylor serves as a Trustee on La Jolla Town Council.
Taylor received her J.D. with an Intellectual Property Concentration from the University of Pacific, McGeorge School of Law in 2013. In law school, she served as the President of the McGeorge Intellectual Property Student Association, President of the Jewish Law Student Association, and was employed as a law clerk at Bell, McAndrews, and Hiltachk, LLP. In addition, she moderated intellectual property law conferences and symposiums with a focus in sports law. Prior to law school, Taylor received a B.A. in Political Science from the University of California Santa Barbara, a Technology Management Certification through the College of Engineering, and a Minor in History.
VP-TS Intellectual Property, Cypress Semiconductor An IP strategist with a combination of technical, business and legal expertise, currently transforming the management of a portfolio of 3000+ patents and applications into a self-funding, business-driven, cross-corporate function delivering entitled ROI. David is also a prolific inventor with over 130 patents granted and pending, and a Patent Agent licensed to practice before the USPTO, reg # 69932. Daivd is responsible for management of a portfolio of ~2000 patents, ~1000 pending applications and the process of IP protection, generation and monetization. Directing systematic review processes to ensure comprehensive and cost-effective protection of strategic IP as it is created. Ensuring maximum ROI on IP$ by implementing systematic reviews of applications against business objectives. Creation, implementation and direction of processes to create and protect strategic IP in emerging technology areas adjacent to existing product lines and technologies.
David Chan is a Senior Patent Counsel at the Western Digital Corporation, where he manages a diverse patent portfolio covering data storage products and the company’s exploratory research efforts. His primary focus includes invention evaluation metrics, portfolio prosecution strategies, and IP issues related to supply chains and customer relationships. He joined Western Digital in 2011, after practicing patent law as an associate at Knobbe Martens and as a patent agent at Coudert Brothers. He is a graduate of Loyola Law School and Harvey Mudd College.
Mr. Cullman a partner in the Orange County office of K&L Gates LLP specializing in intellectual property (IP) law where he manages the transactional IP group. His practice has a strong life sciences focus and concentrates on transactional IP for pharmaceutical and medical device companies including patent procurement, technology transfer and Bayh-Dole issues, merger and acquisition-related due diligence, freedom to operate analyses, non-infringement and invalidity opinions, Hatch-Waxman-related client counseling and litigation support. Mr. Cullman regularly represents pharmaceutical and medical device companies including Allergan, Baxter Biosciences, Beckman Coulter, Medtronic and Spectrum Pharmaceuticals in matters related to product life cycle management, patent litigation strategy and merger and acquisition IP due diligence. Prior to attending law school Mr. Cullman was a licensed Clinical Microbiologist and co-founded and directed an infectious disease laboratory and diagnostic device manufacturing company in Southern California. He has extensive technical experience in the design and manufacturing of in vitro diagnostic devices for infectious diseases, immunology and biochemistry.
Donald Beardsley is Sr. Corporate Counsel for Litigation at Seagate Technology Don oversees the daily operations on Seagate's intellectual property and business litigation. Don is a member of the California Bar and received his BA and MS from the University of California at Santa Cruz and his JD from the Santa Clara University School of Law.
Sanjesh Sharma is Senior IP Counsel at Johnson & Johnson Vision, where she manages all aspects of intellectual property for the company’s Refractive Surgery and Laser Cataract Surgery product lines, including managing domestic and international patent portfolios, litigation support, opposition practice, product clearances, due diligence for asset acquisitions and licensing, as well as copyright and trademark compliance. Before moving in-house, she worked at various national and global law firms, focusing mainly on patent and trademark litigation, licensing, due diligence, and counseling involving a wide range of technologies, including biotechnology, pharmaceuticals, medical devices, and consumer electronics.
Sanjesh received her undergraduate degree in Microbiology from University of California, San Diego, and her law degree from Loyola Law School. She currently serves as a member of the Executive Committee and Chair of the Patent Interest Group for the IP Section of the California State Bar. She regularly speaks on patents and in-house practice, and has been named Rising Star in Intellectual Property by Super Lawyers.
Liz Bui, J.D., Ph.D. oversees all matters related to intellectual property and is instrumental in the execution of corporate partnerships, licensing contracts, and other key business alliances. Prior to joining ViaCyte, Dr. Bui was with the law firm of DLA Piper in the Global Life Science Sector, where she focused on IP asset management and protection strategies. She began her law career as a technology specialist at the firm of Oppenheimer, Wolff & Donnelly. Dr. Bui holds a Ph.D. in cell and molecular biology from the University of California, Los Angeles and was a National Institutes of Health postdoctoral fellow at the University of California, Irvine where her research focused on the biochemistry of Alzheimer’s disease. She received her J.D. from Pepperdine University School of Law in Malibu, California.
Kumar's responsibilities focus on increasing and maintaining the long-term value of the Endologix and its products by means of Intellectual Property (IP) Rights. Drafting and prosecuting patent applications but will likely also extend to work on a variety of other projects, including general IP counseling and patent analysis, and Patent litigation.
Draft and prosecute patent applications.
Supervise U.S. and foreign counsel engaged in drafting and prosecuting patent applications and in post-grant challenges, including inter partes review, post grant review, oppositions and appeals.
Acquire detailed understanding of the technologies, products and R&D activities of the business.
Counsel key technical and business personnel on IP portfolio development and strategies, adversarial proceedings, competitive IP and commercial activities, and licensing opportunities
Conduct landscape searches, patentability reviews, freedom-to-operate analyses, and patent assessments relating to R&D activities, product releases, licensing opportunities and IP acquisition.
Review and assist in drafting agreements relating to the use, transfer or ownership of IP, including non-disclosure, material transfer, professional services, research, collaboration, and license agreements.
Foley & Lardner LLP
Foley & Lardner LLP
November 2006 – Present (8 years)|Los Angeles, Ca
Kumar Maheshwari has more than seven years of intellectual property experience in electronic patent prosecution, trademark acquisition, licensing, technology contracts and various litigation matters. Practice in the medical, mechanical, electrical and computer arts including patent prosecution, due diligence, clearance, invalidity, infringement and related opinion work, in the fields of medical devices and software.
• Provide representation to biotechnology companies such as Medtronic.
• Draft patent applications and responses related to insulin sensing and infusion pumps for Medtronic.
• Prosecute patent applications related to catheter/ stent deployment and drug eluting stent mechanisms.
• Client counseling to medical device and software companies to include IP portfolio strategies and identifying licensing opportunities.
• Drafting patentability, clearance opinions and IP licensing documents.
• Performing a comprehensive risk assessment mapping competitor patients against product landscape
• Conduct IP due diligence for an acquisition of a $250M company
• Draft 200+ new patent applications from disclosure meeting stage.
• Draft 500+ office action responses to USPTO for both domestic and foreign patent applications.
• Draft Inter Partes Review requests, patent and trademark licensing agreements, non-disclosure agreements, pleadings, claim charts for infringement and invalidity contentions.
• Prepare cease and desist letters for patent litigation cases.
Mark P. Wine, a partner in Orrick’s Orange County office, is a member of the Intellectual Property Group. Mark is a trial lawyer with extensive experience in all aspects of intellectual property litigation on behalf of clients in a broad spectrum of technology, business and industry. Mark is also an experienced mediator of intellectual property disputes. He has been in private practice for 40 years and has represented clients in contested intellectual property matters in more than 20 states.
Using his PhD in Biophysical Chemistry, along with 15 + years of in house counsel experience, Richard Hake creates value for companies that run intellectual property-based businesses. He specializes in start up companies, such as Metagenetics Inc. where he serves as Chief Patent Counsel, and also helps "companies in transition" to reduce general and administrative costs, implement systems as management tools, and assist management in due diligence for M&A and licensing transactions. Richard also serves on the board of Legacy Redevelopment and GHM LLC, along with providing pro bono work for non-profit start-up companies. He earned his JD from Northern Kentucky University—Salmon P. Chase College of Law.
Mr. Randy Berholtz is our Executive Vice President, General Counsel and Secretary. He is the former Executive Vice President, General Counsel and Secretary of Apricus Biosciences, Inc. (NASDAQ: APRI), a specialty pharmaceutical company. Prior to that time, he was the Vice President, General Counsel and Secretary of ACON Laboratories, Inc., a group of Chinese and US life sciences companies. He has also been the Chief Operating Officer and General Counsel of IngleWood Ventures, L.P., a life sciences venture capital company and the Interim General Counsel and Secretary of Nanogen, Inc. (NASDAQ: NGEN), a genomics tools company. He has also been an attorney with the law firms of Heller Ehrman, LLP, Cooley Godward, LLP, Kirkpatrick & Lockhart, LLP (now K&L Gates) and Cravath, Swaine & Moore. He has a Bachelor of Arts degree from Cornell University, a Master of Arts degree from Oxford University, where he was a Rhodes Scholar, and a Juris Doctor degree from Yale Law School where he was a Senior Editor of The Yale Law Journal.
Linda is Associate General Counsel at ZL Technologies, a leading information governance software manufacturer and cloud services provider. She has extensive experience in negotiating and drafting contracts for on premise and cloud based offerings, domestic and abroad, including State and Federal government agreements. She negotiates client, reseller and partner channel contracts, oversees the companies trademarks, and an array of issues that arise in the legal department domestic and abroad. Her areas of expertise are in Information Governance/Management and eDiscovery. She has consulted on and been called to testify on such subjects. She has spent over 3 decades in the legal profession and over 15 years focusing on data management initiatives. With many years in the litigation and appellate arena. She has counseled federal and state agencies, the bench, and Fortune 500 entities on the issues around eDiscovery, information governance, data privacy and security. She has partnered with large enterprises as they strive to resolve electronic data, privacy and security issues while balancing an ROI. Linda is a highly sought after speaker and presenter due to her ability to take complex technology concepts and make them understandable. She regularly writes on the above subjects and has been published in many periodicals over the years including, but not limited to, CMSWire, Metropolitan Corporate Counsel Journal, California Lawyer, OLP, ACC Docket and IICJ. She has published works with The Rutter Group and BNA. Linda is a member of the Association of Corporate Counsel, ILTA, ARMA, and a Certified Litigation Support Professional. She sits on the Boards of OLP, and ACC’s Info Governance Committee. She is a member of the California and Washington State Bars, is licensed to practice in the United States District Court for the Central District of California and holds a Masters in Business Administration.
Dan Bikus is Dennemeyer’s Central Region Business Development Manager. Dan has 12+ years’ experience consulting with AmLaw 250 and Fortune 500 legal departments. Dan is a seasoned intellectual property strategist. In his current role, Dan coaches corporate IP legal departments on how to maximize the value of their patent/trademark portfolios, while minimizing any unnecessary spend through Dennemeyer’s suite of services. Dan is a member of the IPO, AIPLA, and INTA. Dan has a Bachelor of Arts Degree in Economics from Illinois State University.
Atabak Royaee is an Associate Director and Corporate Counsel, IP, at Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) located in Ridgefield, Connecticut. In his role at Boehringer, Atabak manages BIPI’s patent portfolios in various therapeutic areas, drafts and prosecutes patent applications, drafts legal opinions, assist in handling IPR proceedings, performs due diligence reviews, and provides counsel to business on licensing and transactional matters. Prior to joining BI, Atabak was an associate attorney at McDermott Will & Emery and LeClairRyan law firms conducting patent prosecution and post-grant proceedings work; and prior to his tenure at law firms, Atabak was a postdoctoral fellow at Harvard School of Public Health and U.S. Department of Agriculture specializing in immunology and infectious disease research. Atabak has B.S. in chemistry and a Ph.D. in biochemistry and molecular biology from Georgetown University, and a law degree from the Suffolk University Law School.
Melissa Scanlan is a Senior Director at T-Mobile and is responsible for all litigation and disputes, as well as proactive risk management, for company matters that implicate intellectual property, antitrust, or significant commercial disputes. In addition, Ms. Scanlan is responsible for antitrust counseling and advice for the company, including antitrust guidance involved in corporate mergers or acquisitions and in network spectrum auctions and bidding behavior. Prior to joining T-Mobile, Ms. Scanlan was Associate General Counsel for InfoSpace, Inc. In that role, Ms. Scanlan managed complex commercial litigation with an emphasis on public securities class action defense. She also advised on proactive risk management practices through contract negotiations. Prior to that, Ms. Scanlan was an associate at Arnold & Porter in Washington, D.C., where she handled antitrust litigation and advocacy before the Department of Justice and the Federal Trade Commission. Ms. Scanlan earned her J.D. from Yale Law School. At Yale, she was a Senior Editor on the Yale Law Journal. She is a member of the Pacific Northwest Planning Committee for ChIPs, an organization dedicated to the advancement, development and retention of women in the IP field.